Literature DB >> 21957148

Intracellular HMGB1 negatively regulates efferocytosis.

Sami Banerjee1, Andressa de Freitas, Arnaud Friggeri, Jaroslaw W Zmijewski, Gang Liu, Edward Abraham.   

Abstract

High mobility group box 1 (HMGB1) is a highly conserved protein with multiple intracellular and extracellular functions, including transcriptional regulation, as well as modulation of inflammation, cell migration, and ingestion of apoptotic cells. In these experiments, we examined a potential role for intracellular HMGB1 in modulating phagocytosis. We found that phagocytosis of apoptotic cells resulted in translocation of HMGB1 into the cytoplasm and extracellular space. Transient or stable inhibition of HMGB1 expression in bone marrow-derived macrophages or fibroblasts resulted in increased phagocytosis of apoptotic thymocytes and apoptotic neutrophils. Knockdown of HMGB1 was associated with enhanced activation of Rac-1 and cytoskeletal rearrangement. Intracellular events involved in phagocytosis and upstream of Rac-1 activation, such as phosphorylation of ERK and focal adhesion kinase (FAK), were increased after knockdown of HMGB1. Inhibition of Src kinase activity prevented the increase in phosphorylation of FAK and ERK present during phagocytosis in HMGB1 knockdown cells, and also abrogated the enhancement in phagocytosis associated with HMGB1 knockdown. Interaction between Src and FAK in the cytoplasm of HMGB1 knockdown fibroblasts was enhanced compared with that present in control fibroblasts. Under in vitro conditions, the presence of HMGB1 diminished interactions between purified FAK and Src. These studies demonstrate a novel role for HMGB1 in the regulation of phagocytosis. In particular, these experiments show that intracellular HMGB1, through associating with Src kinase and inhibiting interactions between Src and FAK, diminishes the phagocytic ability of macrophages and other cell populations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21957148      PMCID: PMC3197890          DOI: 10.4049/jimmunol.1101500

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

Review 1.  Function of Rho family proteins in actin dynamics during phagocytosis and engulfment.

Authors:  G Chimini; P Chavrier
Journal:  Nat Cell Biol       Date:  2000-10       Impact factor: 28.824

Review 2.  Actin dynamics during phagocytosis.

Authors:  F Castellano; P Chavrier; E Caron
Journal:  Semin Immunol       Date:  2001-12       Impact factor: 11.130

Review 3.  New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal.

Authors:  S Müller; P Scaffidi; B Degryse; T Bonaldi; L Ronfani; A Agresti; M Beltrame; M E Bianchi
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

Review 4.  Rho proteins: linking signaling with membrane trafficking.

Authors:  A J Ridley
Journal:  Traffic       Date:  2001-05       Impact factor: 6.215

5.  TIM-4, a receptor for phosphatidylserine, controls adaptive immunity by regulating the removal of antigen-specific T cells.

Authors:  Lee A Albacker; Piia Karisola; Ya-Jen Chang; Sarah E Umetsu; Meixia Zhou; Omid Akbari; Norimoto Kobayashi; Nicole Baumgarth; Gordon J Freeman; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

6.  EGF-induced ERK-activation downstream of FAK requires rac1-NADPH oxidase.

Authors:  Liv Ingrid Flinder; Olga A Timofeeva; Carola M Rosseland; Lene Wierød; Henrik S Huitfeldt; Ellen Skarpen
Journal:  J Cell Physiol       Date:  2011-09       Impact factor: 6.384

7.  CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration.

Authors:  T L Gumienny; E Brugnera; A C Tosello-Trampont; J M Kinchen; L B Haney; K Nishiwaki; S F Walk; M E Nemergut; I G Macara; R Francis; T Schedl; Y Qin; L Van Aelst; M O Hengartner; K S Ravichandran
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

8.  Transcriptional mechanisms of bone morphogenetic protein-induced osteoprotegrin gene expression.

Authors:  M Wan; X Shi; X Feng; X Cao
Journal:  J Biol Chem       Date:  2001-01-03       Impact factor: 5.157

Review 9.  HMGB1 is a therapeutic target for sterile inflammation and infection.

Authors:  Ulf Andersson; Kevin J Tracey
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

10.  HMGB1 inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrin.

Authors:  Arnaud Friggeri; Yanping Yang; Sami Banerjee; Yong-Jun Park; Gang Liu; Edward Abraham
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-08       Impact factor: 4.249

View more
  28 in total

1.  Mitochondria and AMP-activated protein kinase-dependent mechanism of efferocytosis.

Authors:  Shaoning Jiang; Dae Won Park; William S Stigler; Judy Creighton; Saranya Ravi; Victor Darley-Usmar; Jaroslaw W Zmijewski
Journal:  J Biol Chem       Date:  2013-07-29       Impact factor: 5.157

Review 2.  Eat-me: autophagy, phagocytosis, and reactive oxygen species signaling.

Authors:  Philip J Vernon; Daolin Tang
Journal:  Antioxid Redox Signal       Date:  2012-09-18       Impact factor: 8.401

3.  Src Family Kinases in Brain Edema After Acute Brain Injury.

Authors:  DaZhi Liu; Xiong Zhang; BeiLei Hu; Bradley P Ander
Journal:  Acta Neurochir Suppl       Date:  2016

4.  Toll-like receptor 4 engagement inhibits adenosine 5'-monophosphate-activated protein kinase activation through a high mobility group box 1 protein-dependent mechanism.

Authors:  Jean-Marc Tadie; Hong-Beom Bae; Jessy S Deshane; Celeste P Bell; Eduardo R Lazarowski; David D Chaplin; Victor J Thannickal; Edward Abraham; Jaroslaw W Zmijewski
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

Review 5.  Clearance of apoptotic neutrophils and resolution of inflammation.

Authors:  Mallary C Greenlee-Wacker
Journal:  Immunol Rev       Date:  2016-09       Impact factor: 12.988

Review 6.  SR-BI: A Multifunctional Receptor in Cholesterol Homeostasis and Atherosclerosis.

Authors:  MacRae F Linton; Huan Tao; Edward F Linton; Patricia G Yancey
Journal:  Trends Endocrinol Metab       Date:  2017-03-01       Impact factor: 12.015

7.  "With a little help from my friends": efferocytosis as an antimicrobial mechanism.

Authors:  Volker Briken
Journal:  Cell Host Microbe       Date:  2012-09-13       Impact factor: 21.023

Review 8.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

9.  MFG-E8 and HMGB1 are involved in the mechanism underlying alcohol-induced impairment of macrophage efferocytosis.

Authors:  Xiao Wang; Heng-Fu Bu; Wei Zhong; Akihiro Asai; Zhanxiang Zhou; Xiao-di Tan
Journal:  Mol Med       Date:  2013-07-24       Impact factor: 6.354

Review 10.  Recent developments in the role of high-mobility group box 1 in systemic lupus erythematosus.

Authors:  Fleur Schaper; Johanna Westra; Marc Bijl
Journal:  Mol Med       Date:  2014-03-13       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.